SG11202103567RA - Methods of treatment of inflammatory conditions and associated infections - Google Patents

Methods of treatment of inflammatory conditions and associated infections

Info

Publication number
SG11202103567RA
SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA
Authority
SG
Singapore
Prior art keywords
treatment
methods
inflammatory conditions
associated infections
infections
Prior art date
Application number
SG11202103567RA
Other languages
English (en)
Inventor
Wayne Finlayson
Original Assignee
Servatus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018903822A external-priority patent/AU2018903822A0/en
Application filed by Servatus Ltd filed Critical Servatus Ltd
Publication of SG11202103567RA publication Critical patent/SG11202103567RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202103567RA 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections SG11202103567RA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2018903822A AU2018903822A0 (en) 2018-10-10 Compositions and methods of treatment of inflammatory conditions and infections
AU2018903823A AU2018903823A0 (en) 2018-10-10 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2019901175A AU2019901175A0 (en) 2019-04-05 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2019901176A AU2019901176A0 (en) 2019-04-05 Compositions and methods of treatment of inflammatory conditions and associated infections
PCT/AU2019/051092 WO2020073088A1 (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Publications (1)

Publication Number Publication Date
SG11202103567RA true SG11202103567RA (en) 2021-05-28

Family

ID=70163621

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103567RA SG11202103567RA (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Country Status (8)

Country Link
US (1) US20210338749A1 (https=)
EP (1) EP3863656A4 (https=)
JP (1) JP2022504792A (https=)
CN (1) CN114206362A (https=)
AU (1) AU2019356524A1 (https=)
CA (1) CA3124725A1 (https=)
SG (1) SG11202103567RA (https=)
WO (1) WO2020073088A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4255456A4 (en) * 2020-12-01 2024-09-25 Servatus Ltd METHODS TO IMPROVE SLEEP QUALITY
EP4259150A4 (en) * 2020-12-09 2024-12-25 Servatus Ltd COMBINATION THERAPY FOR INFLAMMATORY JOINT DISEASES
EP4387640A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
EP4387639A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
US12185767B2 (en) * 2021-11-05 2025-01-07 Trillium Medical Products, LLC Infused undergarment
AU2022400465A1 (en) * 2021-12-02 2024-07-18 Servatus Ltd Methods for the treatment of constipation
CN115725469B (zh) * 2022-11-28 2024-05-14 广西大学 一株副干酪乳杆菌及其应用
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用
CN117448227B (zh) * 2023-10-31 2024-09-20 西南大学 一株副干酪乳酪杆菌及其在预防和治疗痤疮中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ITMI20032391A1 (it) * 2003-12-05 2005-06-06 Consiglio Nazionale Ricerche Olive da mensa contenenti microrganismi probiotici.
CN102014888A (zh) * 2007-07-03 2011-04-13 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
JP4876262B2 (ja) * 2008-10-24 2012-02-15 防衛省技術研究本部長 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤
WO2011082218A1 (en) * 2009-12-31 2011-07-07 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
ES2660775T3 (es) * 2011-05-16 2018-03-26 Belano Medical Ag Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
WO2014172758A1 (en) * 2013-04-23 2014-10-30 International Marketing Partnerships Pty Ltd Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20150023132A (ko) * 2013-08-23 2015-03-05 (주) 아이투비 아토피 피부용 조성물
CN104000184A (zh) * 2013-12-09 2014-08-27 胡安然 一种调理萎缩性胃炎的膳食
WO2016179639A1 (en) * 2015-05-13 2016-11-17 Markson Ro Probiotic compositions and uses thereof
CN106860441B (zh) * 2017-02-10 2019-12-31 中国医学科学院医药生物技术研究所 4-氧代-2-丁烯酰胺衍生物在制备抑菌剂中的应用
KR101917497B1 (ko) * 2017-02-18 2018-11-09 박병희 신규한 락토바실러스 부크네리 및 이의 용도
TWI607758B (zh) * 2017-03-07 2017-12-11 景岳生物科技股份有限公司 改善乾癬症狀的副乾酪乳桿菌菌株ｇｍｎｌ－６５３及其組合物
AU2018251616B2 (en) * 2017-04-11 2025-04-03 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
EP3764807A4 (en) * 2018-03-14 2021-11-03 Sustainable Community Development, LLC PROBIOTIC AND FOOD ADDITIVE COMPOSITION

Also Published As

Publication number Publication date
EP3863656A4 (en) 2022-06-29
EP3863656A1 (en) 2021-08-18
CN114206362A (zh) 2022-03-18
WO2020073088A1 (en) 2020-04-16
US20210338749A1 (en) 2021-11-04
AU2019356524A1 (en) 2021-05-13
CA3124725A1 (en) 2020-04-16
JP2022504792A (ja) 2022-01-13

Similar Documents

Publication Publication Date Title
SG11202103567RA (en) Methods of treatment of inflammatory conditions and associated infections
IL281277A (en) Preparations and methods for treating viral infections
ZA201801266B (en) Composition and method for treatment and prophylaxis of intestinal infection and inflammation
IL269158A (en) Compositions and methods for treating inflammatory diseases
GB201804514D0 (en) Treatment of pyroptosis
IL272937A (en) Preparations and methods for the treatment of diseases involving fibrosis
IL276053A (en) Therapeutic Gard and methods of its use
EP3615547A4 (en) TREATMENT AND PREVENTION OF KIDNEY DAMAGE
IL260987A (en) Treatment and diagnosis of inflammatory disorders
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
GB201804515D0 (en) Treatment of necroptosis
PT3856213T (pt) Métodos de tratamento de infeções utilizando bactérias
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
PT4112063T (pt) Métodos e tratamento de trauma
PL3781172T3 (pl) Leczenie zapalenia płuc
SG11202003009QA (en) Methods of treating bacterial infections
GB201810923D0 (en) Compositions and method of treatment
HK40056332A (en) Methods of treatment of inflammatory conditions and associated infections
EP3606516A4 (en) METHODS OF TREATMENT AND PREVENTION OF INFECTION
GB201710491D0 (en) Composition and methods of treatment
AU2018903822A0 (en) Compositions and methods of treatment of inflammatory conditions and infections
GB201815000D0 (en) Treatment of hypothroidism and related conditions
AU2019901176A0 (en) Compositions and methods of treatment of inflammatory conditions and associated infections
GB201816914D0 (en) Treatment of inflammation
GB201810925D0 (en) Compositions and methods of treatment